The intracranial pressure monitoring devices market in North America is expected to grow from US$ 715.80 million in 2023 to US$ 960.14 million by 2028. It is estimated to register a CAGR of 6.0% from 2023 to 2028.
Based on offering, the North America intracranial pressure monitoring devices market is segmented into product & systems, solutions & platform, and services. The products and systems segment held the largest share of the North America intracranial pressure monitoring devices market in 2023.
Based on type, the North America intracranial pressure monitoring devices market is segmented into invasive and non-invasive. The invasive segment held a larger share of the North America intracranial pressure monitoring devices market in 2023.
Based on application, the North America intracranial pressure monitoring devices market is segmented into traumatic brain injuries, Reye’s syndrome, non-traumatic bleeds, hydrocephalus, space-occupying lesions, cerebral oedema, and others. The traumatic brain injuries segment held the largest share of the North America intracranial pressure monitoring devices market in 2023.
Based on end user, the North America intracranial pressure monitoring devices market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment held the largest share of the North America intracranial pressure monitoring devices market in 2023.
Based on country, the North America intracranial pressure monitoring devices market is segmented into the US, Canada, and Mexico. The US dominated the North America intracranial pressure monitoring devices market in 2023.
Natus Medical Inc, RAUMEDIC AG, Sophysa SA, Integra LifeSciences Holdings Corp, Medtronic Plc, Braincare Desenvolvimento e Inovacao Tecnologica SA, NovaSignal Corp, Digitimer Ltd, and Longeviti Neuro Solutions LLC are among the leading companies operating in the intracranial pressure monitoring devices market in North America.
Increasing Geriatric Population Fuels North America Intracranial Pressure Monitoring Devices Market
The incidence of neurological disorders has increased significantly among the geriatric population across the region. As per the Medical University of South Carolina, about 75% of strokes occur in people aged 65 years and above in the US. As per the World Health Organization, 20-30% of older people in the US suffered severe head injuries in 2021 as result of falls from standing height. As per the CDC, the number of older people aged 65 and above will be 73 million by 2030 in the US, of which 52 million may experience falls, and 12 million are likely to endure severe injuries due to falls. Similarly, the WHO has also estimated that the world’s population of people aged 60 years and older will double (2.1 billion) by 2050 from 1 billion in 2020. Thus, the growing geriatric population is likely to provide lucrative opportunities for the intracranial pressure (ICP) monitoring devices market during the forecast period.North America Intracranial Pressure Monitoring Devices Market Overview
The North America intracranial pressure (ICP) monitoring devices market is segmented into the US, Canada, and Mexico. The US held the largest share of the North America intracranial pressure (ICP) monitoring devices market in 2021. This is attributed to increasing incidences of traumatic brain injuries (TBIs), rising geriatric population, growing investments in R&D by market players to evaluate new devices, and high per capita healthcare spending in the US.North America Intracranial Pressure Monitoring Devices Market Revenue and Forecast to 2028 (US$ Million)
North America Intracranial Pressure Monitoring Devices Market Segmentation
The North America intracranial pressure monitoring devices market is segmented into offering, type, application, end user, and country.Based on offering, the North America intracranial pressure monitoring devices market is segmented into product & systems, solutions & platform, and services. The products and systems segment held the largest share of the North America intracranial pressure monitoring devices market in 2023.
Based on type, the North America intracranial pressure monitoring devices market is segmented into invasive and non-invasive. The invasive segment held a larger share of the North America intracranial pressure monitoring devices market in 2023.
Based on application, the North America intracranial pressure monitoring devices market is segmented into traumatic brain injuries, Reye’s syndrome, non-traumatic bleeds, hydrocephalus, space-occupying lesions, cerebral oedema, and others. The traumatic brain injuries segment held the largest share of the North America intracranial pressure monitoring devices market in 2023.
Based on end user, the North America intracranial pressure monitoring devices market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment held the largest share of the North America intracranial pressure monitoring devices market in 2023.
Based on country, the North America intracranial pressure monitoring devices market is segmented into the US, Canada, and Mexico. The US dominated the North America intracranial pressure monitoring devices market in 2023.
Natus Medical Inc, RAUMEDIC AG, Sophysa SA, Integra LifeSciences Holdings Corp, Medtronic Plc, Braincare Desenvolvimento e Inovacao Tecnologica SA, NovaSignal Corp, Digitimer Ltd, and Longeviti Neuro Solutions LLC are among the leading companies operating in the intracranial pressure monitoring devices market in North America.
Table of Contents
1. Introduction
3. Research Methodology
4. North America Intracranial Pressure (ICP) Monitoring Devices Market - Market Landscape
5. North America Intracranial Pressure (ICP) Monitoring Devices Market - Key Market Dynamics
6. Intracranial Pressure (ICP) Monitoring Devices Market - North America Analysis
7. North America Intracranial Pressure (ICP) Monitoring Devices Market - Revenue and Forecast to 2028 - By Offerings
8. North America Intracranial Pressure (ICP) Monitoring Devices Market - Revenue and Forecast to 2028 - By Type
9. North America Intracranial Pressure (ICP) Monitoring Devices Market - Revenue and Forecast to 2028 - By Application
10. North America Intracranial Pressure (ICP) Monitoring Devices Market - Revenue and Forecast to 2028 - By End User
11. Intracranial Pressure (ICP) Monitoring Devices Market - Revenue and Forecast to 2028 - Country Analysis
12. Industry Landscape
13. Company Profile
14. Appendix
List of Tables
List of Figure
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Natus Medical Inc
- RAUMEDIC AG
- Sophysa SA
- Integra LifeSciences Holdings Corp
- Medtronic Plc
- Braincare Desenvolvimento e Inovacao Tecnologica SA
- NovaSignal Corp
- Digitimer Ltd
- Longeviti Neuro Solutions LLC
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 139 |
| Published | July 2023 |
| Forecast Period | 2023 - 2028 |
| Estimated Market Value ( USD | $ 715.8 million |
| Forecasted Market Value ( USD | $ 960.14 million |
| Compound Annual Growth Rate | 6.0% |
| Regions Covered | North America |
